6 Matching Annotations
  1. Oct 2026
    1. AU-135F++++++c.1635C>Gp.S545RDynamin

      Case#: Family AU-1, 35yo, female, Austrian

      DiseaseAssertion: DOA+

      FamilyInfo: positive family history, 2 relatives in table 1

      CasePresentingHPOs: HP:0000648, HP:0000365, HP:0001251, HP:0000590, HP:0001138

      CaseHPOFreeText:

      CaseNotHPOs: HP:0003198

      CaseNotHPOFreeText:

      PreviouslyPublished: n/a

      GenotypingMethod: The entire OPA1-coding region and flanking exon–intron boundaries were amplified by the polymerase chain reaction (PCR) and sequenced with BigDye terminator cycle chemistries on an appropriate genetic analyser. All genetic variants were confirmed by reverse sequencing

      Variant: c.1635C>G (p.S545R) aka c.1800C>G (p.S600R)

      ClinVar: 30461

      CAID: CA10575554

      SupplementalData:

    2. FR-130M++++++c.1635C>Gp.S545RDynamin

      Case#: Family FR-1, 30yo, male, French

      DiseaseAssertion: DOA+

      FamilyInfo: positive family history, but no information provided

      CasePresentingHPOs: HP:0000648, HP:0000365, HP:0001251, HP:0003198, HP:0001138

      CaseHPOFreeText:

      CaseNotHPOs:

      CaseNotHPOFreeText:

      PreviouslyPublished: n/a

      GenotypingMethod: The entire OPA1-coding region and flanking exon–intron boundaries were amplified by the polymerase chain reaction (PCR) and sequenced with BigDye terminator cycle chemistries on an appropriate genetic analyser. All genetic variants were confirmed by reverse sequencing

      Variant: c.1635C>G (p.S545R) aka c.1800C>G (p.S600R)

      ClinVar: 30461

      CAID: CA10575554

      SupplementalData:

    1. OA-16c.1635C>Gp.S545R333.71.0-5.020/117020/200 - HM

      Case#: Pedigree OA-16, North of England

      DiseaseAssertion: optic atrophy

      FamilyInfo: 2 additional affected individuals

      CasePresentingHPOs: HP:0000648

      CaseHPOFreeText: Snellen BCVA 20/200 - hand movement, mean age of onset= 3.7yrs

      CaseNotHPOs:

      CaseNotHPOFreeText:

      PreviouslyPublished: Cautious that they may overlap with the individuals from Hudson et al since both are from England, but the author notes that they "checked against the eOPA1 database (http://lbbma.univ-angers.fr/eOPA1/, Accessed 10-12-09) to determine whether they had been described in previous mutational reports."

      GenotypingMethod: The entire coding region of the OPA1 and OPA3 genes was amplified by PCR and sequenced. Variants were confirmed by reverse sequencing.

      Variant: c.1635C>G; p.S545R

      ClinVar: 30461

      CAID: CA10575554

      SupplementalData:

  2. Sep 2026